AAAAAA

   
Results: 1-25 | 26-50 | 51-55
Results: 1-25/55
PHASE-I STUDY OF THE ORALLY-ADMINISTERED BUTYRATE PRODRUG, TRIBUTYRIN, IN PATIENTS WITH SOLID TUMORS
Authors: CONLEY BA EGORIN MJ TAIT N ROSEN DM SAUSVILLE EA DOVER G FRAM RJ VANECHO DA
Citation: Ba. Conley et al., PHASE-I STUDY OF THE ORALLY-ADMINISTERED BUTYRATE PRODRUG, TRIBUTYRIN, IN PATIENTS WITH SOLID TUMORS, Clinical cancer research, 4(3), 1998, pp. 629-634
PHASE-I STUDY OF THE ORALLY-ADMINISTERED BUTYRATE PRODRUG, TRIBUTYRIN, IN PATIENTS WITH SOLID TUMORS
Authors: CONLEY BA EGORIN MJ TAIT N ROSEN DM SAUSVILLE EA DOVER G FRAM RJ VANECHO DA
Citation: Ba. Conley et al., PHASE-I STUDY OF THE ORALLY-ADMINISTERED BUTYRATE PRODRUG, TRIBUTYRIN, IN PATIENTS WITH SOLID TUMORS, Clinical cancer research, 4(3), 1998, pp. 629-634
EVALUATION OF BIOMARKERS OF SURVIVAL RESPONSE IN HORMONE-REFRACTORY PROSTATE-CANCER PATIENTS TREATED WITH SURAMIN
Authors: SRIDHARA R EISENBERGER MA SINIBALDI VJ REYNO LM EGORIN MJ
Citation: R. Sridhara et al., EVALUATION OF BIOMARKERS OF SURVIVAL RESPONSE IN HORMONE-REFRACTORY PROSTATE-CANCER PATIENTS TREATED WITH SURAMIN, Cancer epidemiology, biomarkers & prevention, 7(7), 1998, pp. 631-634
PHARMACOKINETIC (PK) AND PHARMACODYNAMIC (PD) ANALYSIS OF A PHASE-I STUDY OF TAXOL((R))(T), CARBOPLATIN (C) WITH P-GLYCOPROTEIN (P-GP) MODULATOR PSC-833 (PSC)
Authors: MICHAEL M OZA A EGORIN MJ PATNAIK A FIRBY P SIU LL LITCHMAN M MOORE MJ
Citation: M. Michael et al., PHARMACOKINETIC (PK) AND PHARMACODYNAMIC (PD) ANALYSIS OF A PHASE-I STUDY OF TAXOL((R))(T), CARBOPLATIN (C) WITH P-GLYCOPROTEIN (P-GP) MODULATOR PSC-833 (PSC), Annals of oncology, 9, 1998, pp. 621-621
PHASE-I AND PHARMACOKINETIC TRIAL OF PACLITAXEL IN PATIENTS WITH HEPATIC-DYSFUNCTION - CANCER AND LEUKEMIA GROUP-B-9264
Authors: VENOOK AP EGORIN MJ ROSNER GL BROWN TD JAHAN TM BATIST G HOHL R BUDMAN D RATAIN MJ KEARNS CM SCHILSKY RL
Citation: Ap. Venook et al., PHASE-I AND PHARMACOKINETIC TRIAL OF PACLITAXEL IN PATIENTS WITH HEPATIC-DYSFUNCTION - CANCER AND LEUKEMIA GROUP-B-9264, Journal of clinical oncology, 16(5), 1998, pp. 1811-1819
HIGH-DOSE INTRAVENOUS METHOTREXATE FOR PATIENTS WITH NONLEUKEMIC LEPTOMENINGEAL CANCER - IS INTRATHECAL CHEMOTHERAPY NECESSARY
Authors: GLANTZ MJ COLE BF RECHT L AKERLEY W MILLS P SARIS S HOCHBERG F CALABRESI P EGORIN MJ
Citation: Mj. Glantz et al., HIGH-DOSE INTRAVENOUS METHOTREXATE FOR PATIENTS WITH NONLEUKEMIC LEPTOMENINGEAL CANCER - IS INTRATHECAL CHEMOTHERAPY NECESSARY, Journal of clinical oncology, 16(4), 1998, pp. 1561-1567
PLASMA-CONCENTRATIONS AND PHARMACOKINETICS OF DIMETHYLSULFOXIDE AND ITS METABOLITES IN PATIENTS UNDERGOING PERIPHERAL-BLOOD STEM-CELL TRANSPLANTS
Authors: EGORIN MJ ROSEN DM SRIDHARA R SENSENBRENNER L COTTLERFOX M
Citation: Mj. Egorin et al., PLASMA-CONCENTRATIONS AND PHARMACOKINETICS OF DIMETHYLSULFOXIDE AND ITS METABOLITES IN PATIENTS UNDERGOING PERIPHERAL-BLOOD STEM-CELL TRANSPLANTS, Journal of clinical oncology, 16(2), 1998, pp. 610-615
PHASE-I AND PHARMACOLOGICAL STUDY OF CONTINUOUS-INFUSION TOPOTECAN INCOMBINATION WITH CISPLATIN IN PATIENTS WITH ADVANCED CANCER - A CANCER AND LEUKEMIA GROUP-B STUDY
Authors: LILENBAUM RC MILLER AA BATIST G BERNARD S HOLLIS DR ROSNER GL EGORIN MJ SCHILSKY RL RATAIN MJ
Citation: Rc. Lilenbaum et al., PHASE-I AND PHARMACOLOGICAL STUDY OF CONTINUOUS-INFUSION TOPOTECAN INCOMBINATION WITH CISPLATIN IN PATIENTS WITH ADVANCED CANCER - A CANCER AND LEUKEMIA GROUP-B STUDY, Journal of clinical oncology, 16(10), 1998, pp. 3302-3309
OVERVIEW OF RECENT TOPICS IN CLINICAL-PHARMACOLOGY OF ANTICANCER AGENTS
Authors: EGORIN MJ
Citation: Mj. Egorin, OVERVIEW OF RECENT TOPICS IN CLINICAL-PHARMACOLOGY OF ANTICANCER AGENTS, Cancer chemotherapy and pharmacology, 42, 1998, pp. 22-30
METABOLISM OF 17-(ALLYLAMINO)-17-DEMETHOXYGELDANAMYCIN (NSC-330507) BY MURINE AND HUMAN HEPATIC PREPARATIONS
Authors: EGORIN MJ ROSEN DM WOLFF JH CALLERY PS MUSSER SM EISEMAN JL
Citation: Mj. Egorin et al., METABOLISM OF 17-(ALLYLAMINO)-17-DEMETHOXYGELDANAMYCIN (NSC-330507) BY MURINE AND HUMAN HEPATIC PREPARATIONS, Cancer research, 58(11), 1998, pp. 2385-2396
ANTHRACYCLINE ANTIBIOTIC BLOCKADE OF SV40 T-ANTIGEN HELICASE ACTION
Authors: BACHUR NR LUN L SUN PM TRUBEY CM ELLIOTT EE EGORIN MJ MALKAS L HICKEY R
Citation: Nr. Bachur et al., ANTHRACYCLINE ANTIBIOTIC BLOCKADE OF SV40 T-ANTIGEN HELICASE ACTION, Biochemical pharmacology, 55(7), 1998, pp. 1025-1034
PREDICTION OF CARBOPLATIN CLEARANCE FROM STANDARD MORPHOLOGICAL AND BIOLOGICAL PATIENT CHARACTERISTICS
Authors: FUJIWARA Y TAKAHASHI T YAMAKIDO M OHUNE T TSUYA T EGORIN MJ
Citation: Y. Fujiwara et al., PREDICTION OF CARBOPLATIN CLEARANCE FROM STANDARD MORPHOLOGICAL AND BIOLOGICAL PATIENT CHARACTERISTICS, Journal of the National Cancer Institute, 89(3), 1997, pp. 260-261
EARLY BACTERICIDAL ACTIVITY OF ISONIAZID IN PULMONARY TUBERCULOSIS - OPTIMIZATION OF METHODOLOGY
Authors: HAFNER R COHN JA WRIGHT DJ DUNLAP NE EGORIN MJ ENAMA ME MUTH K PELOQUIN CA MOR N HEIFETS LB DUNLAP N PHILLIPS P CAMPO R JAMES P SENSION M BOURIE M WITT M KRUGER S MUSHATT D GREENSPAN D
Citation: R. Hafner et al., EARLY BACTERICIDAL ACTIVITY OF ISONIAZID IN PULMONARY TUBERCULOSIS - OPTIMIZATION OF METHODOLOGY, American journal of respiratory and critical care medicine, 156(3), 1997, pp. 918-923
WEEKLY PACLITAXEL WITH AND WITHOUT CONCURRENT RADIATION-THERAPY - TOXICITY, PHARMACOKINETICS, AND RESPONSE
Authors: GLANTZ MJ CHOY H AKERLEY W KEARNS CM EGORIN MJ RHODES CH COLE BF
Citation: Mj. Glantz et al., WEEKLY PACLITAXEL WITH AND WITHOUT CONCURRENT RADIATION-THERAPY - TOXICITY, PHARMACOKINETICS, AND RESPONSE, Seminars in radiation oncology, 7(2), 1997, pp. 25-33
THE SAFETY AND PHARMACOKINETICS OF SINGLE-AGENT AND COMBINATION THERAPY WITH MEGESTROL-ACETATE AND DRONABINOL FOR THE TREATMENT OF HIV WASTING SYNDROME
Authors: TIMPONE JG WRIGHT DJ LI N EGORIN MJ ENAMA ME MAYERS J GALETTO G GAGNON S VARGO J CHIRGWIN K MARCEL A COHN D HOPKINS B DUDLEY M GELETKO S STANDIFORD H CERVINO K MUSHATT DM GREENSPAN D POWDERLY W MEYERS M SAMPSON JH MCMILLAN G NOVAK R MOREIRA L
Citation: Jg. Timpone et al., THE SAFETY AND PHARMACOKINETICS OF SINGLE-AGENT AND COMBINATION THERAPY WITH MEGESTROL-ACETATE AND DRONABINOL FOR THE TREATMENT OF HIV WASTING SYNDROME, AIDS research and human retroviruses, 13(4), 1997, pp. 305-315
IN-VITRO METABOLISM BY MOUSE AND HUMAN LIVER PREPARATIONS OF HALOMON,AN ANTITUMOR HALOGENATED MONOTERPENE
Authors: EGORIN MJ ROSEN DM BENJAMIN SE CALLERY PS SENTZ DL EISEMAN JL
Citation: Mj. Egorin et al., IN-VITRO METABOLISM BY MOUSE AND HUMAN LIVER PREPARATIONS OF HALOMON,AN ANTITUMOR HALOGENATED MONOTERPENE, Cancer chemotherapy and pharmacology, 41(1), 1997, pp. 9-14
PHASE-I CLINICAL-TRIAL OF ALL-TRANS-RETINOIC ACID WITH CORRELATION OFITS PHARMACOKINETICS AND PHARMACODYNAMICS
Authors: CONLEY BA EGORIN MJ SRIDHARA R FINLEY R HEMADY R WU SL TAIT NS VANECHO DA
Citation: Ba. Conley et al., PHASE-I CLINICAL-TRIAL OF ALL-TRANS-RETINOIC ACID WITH CORRELATION OFITS PHARMACOKINETICS AND PHARMACODYNAMICS, Cancer chemotherapy and pharmacology, 39(4), 1997, pp. 291-299
CONSIDERATIONS REGARDING THE LESS-THAN-EXPECTED THROMBOCYTOPENIA ENCOUNTERED WITH COMBINATION PACLITAXEL CARBOPLATIN CHEMOTHERAPY/
Authors: KEARNS CM EGORIN MJ
Citation: Cm. Kearns et Mj. Egorin, CONSIDERATIONS REGARDING THE LESS-THAN-EXPECTED THROMBOCYTOPENIA ENCOUNTERED WITH COMBINATION PACLITAXEL CARBOPLATIN CHEMOTHERAPY/, Seminars in oncology, 24(1), 1997, pp. 91-96
COMPARATIVE MOLECULAR-FIELD ANALYSIS-BASED PREDICTIVE MODEL OF STRUCTURE-FUNCTION-RELATIONSHIPS OF POLYAMINE TRANSPORT INHIBITORS IN L1210 CELLS
Authors: LI YL MACKERELL AD EGORIN MJ BALLESTEROS MF ROSEN DM WU YY BLAMBLE DA CALLERY PS
Citation: Yl. Li et al., COMPARATIVE MOLECULAR-FIELD ANALYSIS-BASED PREDICTIVE MODEL OF STRUCTURE-FUNCTION-RELATIONSHIPS OF POLYAMINE TRANSPORT INHIBITORS IN L1210 CELLS, Cancer research, 57(2), 1997, pp. 234-239
LONG-TERM FOLLOW-UP OF SYMPTOMATIC HIV-INFECTED PATIENTS ORIGINALLY RANDOMIZED TO EARLY VERSUS LATER ZIDOVUDINE TREATMENT - REPORT OF A VETERANS AFFAIRS COOPERATIVE STUDY
Authors: SIMBERKOFF MS HARTIGAN PM HAMILTON JD DAY PL DIAMOND GR DICKINSON GM DRUSANO GL EGORIN MJ GEORGE WL GORDIN FM HAWKES CA JENSEN PC KLIMAS NG LABRIOLA AM LAHART CJ OBRIEN WA OSTER CN WEINHOLD KJ WRAY NP PAZNER SBZ
Citation: Ms. Simberkoff et al., LONG-TERM FOLLOW-UP OF SYMPTOMATIC HIV-INFECTED PATIENTS ORIGINALLY RANDOMIZED TO EARLY VERSUS LATER ZIDOVUDINE TREATMENT - REPORT OF A VETERANS AFFAIRS COOPERATIVE STUDY, Journal of acquired immune deficiency syndromes and human retrovirology, 11(2), 1996, pp. 142-150
PHASE-I STUDY OF WEEKLY OUTPATIENT PACLITAXEL AND CONCURRENT CRANIAL IRRADIATION IN ADULTS WITH ASTROCYTOMAS
Authors: GLANTZ MJ CHOY H KEARNS CM COLE BF MILLS P ZUHOWSKI EG SARIS S RHODES CH STOPA E EGORIN MJ
Citation: Mj. Glantz et al., PHASE-I STUDY OF WEEKLY OUTPATIENT PACLITAXEL AND CONCURRENT CRANIAL IRRADIATION IN ADULTS WITH ASTROCYTOMAS, Journal of clinical oncology, 14(2), 1996, pp. 600-609
PLASMA PHARMACOKINETICS, BIOAVAILABILITY, AND TISSUE DISTRIBUTION IN CD2F1 MICE OF HALOMON, AN ANTITUMOR HALOGENATED MONOTERPENE ISOLATED FROM THE RED ALGAE PORTIERIA-HORNEMANNII
Authors: EGORIN MJ SENTZ DL ROSEN DM BALLESTEROS MF KEARNS CM CALLERY PS EISEMAN JL
Citation: Mj. Egorin et al., PLASMA PHARMACOKINETICS, BIOAVAILABILITY, AND TISSUE DISTRIBUTION IN CD2F1 MICE OF HALOMON, AN ANTITUMOR HALOGENATED MONOTERPENE ISOLATED FROM THE RED ALGAE PORTIERIA-HORNEMANNII, Cancer chemotherapy and pharmacology, 39(1-2), 1996, pp. 51-60
PLASMA PHARMACOKINETICS AND URINARY-EXCRETION OF THE POLYAMINEANALOGUE 1,19-BIS(ETHYLAMINO)-5,10,15-TRIAZANONADECANE IN CD2F1 MICE
Authors: EISEMAN JL YUAN ZM EDDINGTON ND SENTZ DL GALLERY PS EGORIN MJ
Citation: Jl. Eiseman et al., PLASMA PHARMACOKINETICS AND URINARY-EXCRETION OF THE POLYAMINEANALOGUE 1,19-BIS(ETHYLAMINO)-5,10,15-TRIAZANONADECANE IN CD2F1 MICE, Cancer chemotherapy and pharmacology, 38(1), 1996, pp. 13-20
A PHASE I II STUDY OF HIGH-DOSE CYCLOPHOSPHAMIDE, CISPLATIN, AND THIOTEPA FOLLOWED BY AUTOLOGOUS BONE-MARROW AND GRANULOCYTE-COLONY-STIMULATING FACTOR-PRIMED PERIPHERAL-BLOOD PROGENITOR CELLS IN PATIENTS WITH ADVANCED MALIGNANCIES/
Authors: HUSSEIN AM PETROS WP ROSS M VREDENBURGH JJ AFFRONTI ML JONES RB SHPALL EJ RUBIN P ELKORDY M GILBERT C GUPTON C EGORIN MJ SOPER J BERCHUCK A CLARKEPEARSON D BERRY DA PETERS WP
Citation: Am. Hussein et al., A PHASE I II STUDY OF HIGH-DOSE CYCLOPHOSPHAMIDE, CISPLATIN, AND THIOTEPA FOLLOWED BY AUTOLOGOUS BONE-MARROW AND GRANULOCYTE-COLONY-STIMULATING FACTOR-PRIMED PERIPHERAL-BLOOD PROGENITOR CELLS IN PATIENTS WITH ADVANCED MALIGNANCIES/, Cancer chemotherapy and pharmacology, 37(6), 1996, pp. 561-568
A COMPARISON OF METHODS FOR LIMITED-SAMPLING STRATEGY DESIGN USING DATA FROM A PHASE-I TRIAL OF THE ANTHRAPYRAZOLE DUP-941
Authors: JODRELL DI MURRAY LS HAWTOF J GRAHAM MA EGORIN MJ
Citation: Di. Jodrell et al., A COMPARISON OF METHODS FOR LIMITED-SAMPLING STRATEGY DESIGN USING DATA FROM A PHASE-I TRIAL OF THE ANTHRAPYRAZOLE DUP-941, Cancer chemotherapy and pharmacology, 37(4), 1996, pp. 356-362
Risultati: 1-25 | 26-50 | 51-55